A summary of the latest developments from 12 studies in BTK inhibition in B-cell malignancies presented at EHA2022.
The Satellite Symposium at EHA2022 was chaired by Paolo Ghia joined by Federico Pea, Barbara Eichhorst, Shirley D’Sa and Ramón García Sanz. They discussed next-generation BTK inhibitors in the treatment of B-cell malignancies.
Report on targeted and immune-directed therapies in B-cell malignancies presented at ASCO, EHA and ICML 2021.
Report on recent developments in the treatment of B-cell malignancies presented at ASCO, EHA and ICML 2021.